Scientists have identified a protein that could be the key in the development of Alzheimer's disease. The new discovery could provide a new drug target for dementia.
Known as GPR3, the protein is believed to play an important role in reducing the buildup of amyloid plaques in the brain, a hallmark of Alzheimer's disease, said the findings published in Science Translational Medicine.
Alzheimers Disease
Alzheimer''s disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.
Advertisement
Research on mice with four different varieties of dementia showed that genetically deleting GPR3 resulted in cognitive improvement and reduced signs of disease in the brain.
But since mouse models of Alzheimer's disease are not directly equivalent to the human condition, more research is needed to determine if the same process could work in people.
![Inability to Recognize Familiar Smells Could Signal Alzheimers]( "Inability to Recognize Familiar Smells Could Signal Alzheimers")
People who have difficulty recognizing familiar smells could be experiencing an early sign of Alzheimer's disease, according to a study published Monday.
Researchers are encouraged by the fact that about half of all drugs currently on the market target this type of receptor, known as a G protein-coupled receptor.
Also, autopsies on the brains of people with Alzheimer's have shown that a subset of patients show high levels of GPR3, and that these levels were associated with advancement of the disease.
The study "is an example of how testing a drug target in multiple disease-relevant models can build a strong case to convince the pharmaceutical industry to launch a drug development program for Alzheimer's disease," the authors wrote.
There is no cure for Alzheimer's disease, the most common type of dementia, and no drug treatment that has been shown to stop its progressions.
More than 46 million people worldwide suffer from dementia, and cases are expected to balloon to 131.5 million by 2050 due to the aging population.
Source: AFP
Inability to Recognize Familiar Smells Could Signal Alzheimers
People who have difficulty recognizing familiar smells could be experiencing an early sign of Alzheimer's disease, according to a study published Monday.
Advertisement
Researchers are encouraged by the fact that about half of all drugs currently on the market target this type of receptor, known as a G protein-coupled receptor.
Also, autopsies on the brains of people with Alzheimer's have shown that a subset of patients show high levels of GPR3, and that these levels were associated with advancement of the disease.
The study "is an example of how testing a drug target in multiple disease-relevant models can build a strong case to convince the pharmaceutical industry to launch a drug development program for Alzheimer's disease," the authors wrote.
There is no cure for Alzheimer's disease, the most common type of dementia, and no drug treatment that has been shown to stop its progressions.
More than 46 million people worldwide suffer from dementia, and cases are expected to balloon to 131.5 million by 2050 due to the aging population.
Source: AFP
Risk Factors for Alzheimers Disease
Cognitively normal adults exhibiting atrophy of their temporal lobe or damage to blood vessels in the brain are more likely to develop Alzheimer's disease.
Advertisement
Brain Protein Could be Targeted to Slow Alzheimer’s, Study Reveals
A protein that is involved in limiting flexibility in the aging brain could be targeted by new treatments which can slow the progression of Alzheimer's disease.
Advertisement
Recommended Reading
Latest Research News
Limb savage procedure benefits patients with severe vascular disease who are at risk for amputation of their limbs.
Does omega-3 help Alzheimer's patients? A new form of omega-3 helped restore specific markers of eye health in mice bred with aspects of early-onset Alzheimer's disease.
Drugs used to inhibit the physiological responses for allergic reactions lessen osteoarthritis risk, revealed research.
The International Space Station will be used to carry out experiments seeking to improve understanding of incurable child brain tumors and the muscle aging process.
How many people in the UK have misophonia? In a representative sample study, most people had at least some irritation upon hearing trigger sounds.
